Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein

Elife. 2017 Dec 26:6:e29123. doi: 10.7554/eLife.29123.


The discovery of the causative gene for Huntington's disease (HD) has promoted numerous efforts to uncover cellular pathways that lower levels of mutant huntingtin protein (mHtt) and potentially forestall the appearance of HD-related neurological defects. Using a cell-based model of pathogenic huntingtin expression, we identified a class of compounds that protect cells through selective inhibition of a lipid kinase, PIP4Kγ. Pharmacological inhibition or knock-down of PIP4Kγ modulates the equilibrium between phosphatidylinositide (PI) species within the cell and increases basal autophagy, reducing the total amount of mHtt protein in human patient fibroblasts and aggregates in neurons. In two Drosophila models of Huntington's disease, genetic knockdown of PIP4K ameliorated neuronal dysfunction and degeneration as assessed using motor performance and retinal degeneration assays respectively. Together, these results suggest that PIP4Kγ is a druggable target whose inhibition enhances productive autophagy and mHtt proteolysis, revealing a useful pharmacological point of intervention for the treatment of Huntington's disease, and potentially for other neurodegenerative disorders.

Keywords: D. melanogaster; Huntington; autophagy; human; human biology; lipid kinase; medicine; neuroscience.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy
  • Cells, Cultured
  • Disease Models, Animal
  • Drosophila
  • Enzyme Inhibitors / metabolism*
  • Fibroblasts / physiology
  • Gene Knockdown Techniques
  • Humans
  • Huntingtin Protein / metabolism*
  • Huntington Disease / prevention & control*
  • Mice
  • Models, Biological
  • Neurons / physiology
  • Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors*
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Protein Aggregation, Pathological
  • Proteolysis


  • Enzyme Inhibitors
  • HTT protein, human
  • Huntingtin Protein
  • PIP4kgamma protein, human
  • Phosphotransferases (Alcohol Group Acceptor)